Literature DB >> 23023462

Adolescent synthetic cannabinoid exposures reported to Texas poison centers.

Mathias B Forrester1.   

Abstract

OBJECTIVE: This study describes the pattern of adolescent synthetic cannabinoid exposures reported to a large statewide poison center system.
METHODS: Synthetic cannabinoid exposures among patients younger than 20 years reported to Texas poison centers during January 2010 to June 2011 were identified. The distribution of exposures by various demographic and clinical factors was determined.
RESULTS: For 305 adolescent exposures, the mean age was 16.7 years (range, 12-19 y). The exposure was by inhalation in 77.4% of the cases, and 72.1% involved males. The exposure site was the patient's own residence in 70.5% of the cases, and a health care facility was the caller site in 68.9%. The patient was already at or en route to a health care facility in 80.3% of the cases, and the medical outcome was serious in 61.0%. The most frequently reported adverse clinical effects were tachycardia (41.6%), drowsiness/lethargy (24.3%), agitation/irritability (16.4%), vomiting (13.1%), hallucinations/delusions (11.5%), nausea (8.5%), confusion (8.2%), hypertension (7.5%), chest pain (6.9%), and dizziness/vertigo (5.2%).
CONCLUSIONS: Adolescent synthetic cannabinoid exposures reported to Texas poison centers were more likely to involve inhalation. The adolescents were more likely to be male. The exposures more often occurred at the patient's own residence and managed at a health care facility with a serious outcome. This pattern of exposures was similar to that observed among adults.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023462     DOI: 10.1097/PEC.0b013e31826c9a97

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  11 in total

1.  Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.

Authors:  Sherrica Tai; William E Fantegrossi
Journal:  Curr Addict Rep       Date:  2014-06-01

2.  Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Authors:  Francois R Lamy; Raminta Daniulaityte; Ramzi W Nahhas; Monica J Barratt; Alan G Smith; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2017-06-01

Review 3.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

4.  Driving under the influence of synthetic cannabinoids ("Spice"): a case series.

Authors:  Frank Musshoff; Burkhard Madea; Gerhard Kernbach-Wighton; Wolfgang Bicker; Stefan Kneisel; Melanie Hutter; Volker Auwärter
Journal:  Int J Legal Med       Date:  2013-05-01       Impact factor: 2.686

5.  Novel psychoactive substances in young adults with and without psychiatric comorbidities.

Authors:  Giovanni Martinotti; Matteo Lupi; Tiziano Acciavatti; Eduardo Cinosi; Rita Santacroce; Maria Salvina Signorelli; Laura Bandini; Giulia Lisi; Diego Quattrone; Paola Ciambrone; Andrea Aguglia; Federica Pinna; Salvatore Calò; Luigi Janiri; Massimo di Giannantonio
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 6.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 7.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20

8.  The Effect of Synthetic Cannabinoids on P-Wave Dispersion: An Observational Study.

Authors:  Esra Aydin Sunbul; Murat Sunbul; Ayse Terzi; Sumeyye Calli; Esra Koca; Rabia Bilici; Serhat Citak
Journal:  Med Princ Pract       Date:  2016-06-10       Impact factor: 1.927

Review 9.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

10.  Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB).

Authors:  Priyanka Parajuli; Manjari Rani Regmi; Odalys Estefania Lara-Garcia; Ismael Abu Limon; Alan Deckard
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.